XORTX Therapeutics appoints Allan Williams and Paul Van Damme to its Board of Directors
– CANADA, Calgary – XORTX Therapeutics Inc. (CSE:XRX), a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces the appointment of Allan Williams and Paul Van Damme as directors of the Company and the resignation of Dr.…